Recent

% | $
Quotes you view appear here for quick access.

Oclaro, Inc. Message Board

mephistocrat 21 posts  |  Last Activity: Feb 19, 2015 10:08 AM Member since: Jun 5, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Cytori Therapeutics currently has a Zacks Rank #1 BUY) while its Earnings ESP is 6.00

    Sentiment: Strong Buy

  • Reply to

    I dont own ibio....

    by jonj49307 Feb 17, 2015 7:15 PM
    mephistocrat mephistocrat Feb 17, 2015 10:21 PM Flag

    IBIO has first in-first out on their IbioLaunch Platform expression system patents so the US GOVT HHS is who will award contract for the plant-maker to mass produce 20,000 doses and the govt has to honor their new first-in-first-out worldwide patent policy which makes any plant-maker like CALIBER BIO have to use Ibio licenses or if not them, then whomever has to contact Ibio to license and use their expression platforms so Ibio is in no matter what... what CEO Kay was hinting at....

    Sentiment: Strong Buy

  • Reply to

    Good luck and peace out.

    by sean1664vmax Feb 17, 2015 4:24 PM
    mephistocrat mephistocrat Feb 17, 2015 8:31 PM Flag

    You did no research on IBIO else you would have never sold so cheaply and so fast--if an investor will pay you 1.30 for each share, that same investor is willing to go 30-40% higher if he/she is buying into Ibio after the run-up, then they want the stock enough to pay up to 2.00 and then some... investors like you turn the stock into a buyers market when it should be the sellers who determine end of day stock prices.... amateur

    Sentiment: Strong Buy

  • Reply to

    mephistocrat!!!

    by starteam003 Feb 17, 2015 3:08 PM
    mephistocrat mephistocrat Feb 17, 2015 5:18 PM Flag

    Ibio is certain of being part of a us govt contract or funding to produce zmapp---yes that is a done deal because their patents were filed first and way before any other bio company that uses expression platforms for plant making proteins and antibodies... Ibiolaunch platform will be used to produce hybrid plants to harvest zmapp treatments for sure.

    Sentiment: Strong Buy

  • mephistocrat mephistocrat Feb 17, 2015 4:19 PM Flag

    Ebola Ebov Zaire is not even close to what you call an orphan disease: it has a kill rate of 80% each time it appears on the scene and it will get worse as the wet season begins next month--this time last year, Ebola cases began being reported--hell, just week, the US Army had to completely close down a town in Guinea, where no one left or entered due to new outbreak of Ebola cases--does that sound like an orphan disease? Ebola was never controlled last year, the dry season began and the new cases went down some but stayed steady. Ebola Zaire has the ability to mutate or edit itself in order to keep replicating: us military called it genetic drift: viruses are already dead until they enter the bloodstream, then they frankenstein your body. IBIO INC OWNS THE FIRST RIGHTS AND PATENTS FOR PLANT MAKING EXPRESSION PLATFORMS IN THE USA WHICH MEANS ANY PLANT MAKING ANTIBODIES FOR ZMAPP HAVE TO INCLUDE IBIOLAUNCH PLATFORMS, DUH.... THEY ARE GUARANTEED MONEY!

    Sentiment: Strong Buy

  • mephistocrat mephistocrat Feb 17, 2015 4:00 PM Flag

    Washington was closed for snow emergency today idiot--tomorrow fda will be open for business and so will the us defense dept agencies---that is why..

    Sentiment: Strong Buy

  • Those who sold ibio today will hate themselves tomorrow and especially by the end of this week-ibio and zmapp are tied at the hip due to ibio patents

    Sentiment: Strong Buy

  • 60 minutes report on zmapp not being approved already
    the gist of bob simon's last report was that the us govt has been very slow in making zmapp, the only proven ebola evbov treatment, approved for fast track designation by fda firstly, so then the us govt can award contract/funding to hybrid plant maker who uses ibio inc ibiolaunch platform because ibio filed their patents on plant expression processes first in the usa, which means any zmapp production other than kentucky bio, which is too small, has to use ibio platforms in order to get…

    Sentiment: Strong Buy

  • mephistocrat mephistocrat Feb 17, 2015 3:29 PM Flag

    Up over 100% in two days is one helluva stock to me....

    Sentiment: Strong Buy

  • Reply to

    buy and hold--get rich

    by ivodirect Feb 17, 2015 3:18 PM
    mephistocrat mephistocrat Feb 17, 2015 3:27 PM Flag

    I agree due to ibio inc already assured of being a key player in any zmapp plant making/treatment production by virtue of their having filed their platform expression patents first in the usa, and drug patents are very binding and have to be honored by the us govt in contracts or funding plant making companies like caliber biotherapeutics--kentucky bio is way too small for zmapp on a large scale so as soon as fda approves zmapp, which should be this week at the latest, ibio will then be mentioned with zmapp a helluva lot ))

    Sentiment: Strong Buy

  • Reply to

    mephistocrat!!!

    by starteam003 Feb 17, 2015 3:08 PM
    mephistocrat mephistocrat Feb 17, 2015 3:15 PM Flag

    Ibio inc due to their usa patents filed first already assures them of exposure when zmapp is approved by the fda for fast track designation--which is guaranteed with all the heat 60 minutes put on barda for not doing anything and for being way too slow to respond to ebola threat in usa. Ibio's ibiolaunch platform is guaranteed to be used to make zmapp so caliber bio has already got any us govt funding or contracts signed and waiting for the fda to thumbs up on zmapp submitted by leaf bio for fda approval a few weeks ago... 60 minutes report was to get them to do it faster... That is all.... Relaz

    Sentiment: Strong Buy

  • mephistocrat mephistocrat Feb 17, 2015 2:52 PM Flag

    Patent law for drugs in the usa are entirely different in application--in other words, and apple didnt file the first patents for smartphone technology cause any filing would have had to be much more precise, idiot... ))

    Sentiment: Strong Buy

  • Reply to

    good news again would be fun :)

    by soeazy Feb 17, 2015 2:18 PM
    mephistocrat mephistocrat Feb 17, 2015 2:28 PM Flag

    Here is good news: reason ibio wasnt mentioned in 6o minutes report sunday was because the us govt has to include ibio inc and its ibiolaunch platform due to their filing their plant expressions platform patents first. First come, first served is patent law in usa and worldwide. Any zmapp production on a large scale has to use ibio inc platforms due to their patents giving them exclusive rights when it comes to expression platform technology.... So ibio was always in with zmapp so why mention them...?

    Sentiment: Strong Buy

  • Reply to

    run to 30,000,000 shares $1.35 at close.......

    by bierds61 Feb 17, 2015 2:06 PM
    mephistocrat mephistocrat Feb 17, 2015 2:24 PM Flag

    What most people do not know is that IBIO's patents in the USA were filed first on plant making hybrid expression platform technologies so the US GOVT agencies have to contract with a plant-maker facility that uses IbioLaunch Platforms in order to get awarded any govt contract or funding due to Ibio's patents being filed before all others; its the law or patent law in the USA. So Ibio Inc always was going to be part of any large scale ZMAPP plant production/treatments in the USA based on their patents. Why their patents are so important in the usa and worldwide: they filed them before everyone else.... ))

    Sentiment: Strong Buy

  • Ibio inc's usa patents were filed first therefore in plant maker other than kentucky bioprocessing will have to use ibiolaunch platform for expressions in growing any hybrid zmapp antibody cocktail proteins. Caliber bio uses ibiolaunch already and has been using nicotania plants for antibody production for some time, so it is a sure thing that caliber bio gets the us govt contracts when zmapp gets fda fast track designation approval this week...

    Sentiment: Strong Buy

  • May wait for fda to fast track zmapp as map/leaf pharma has submitted it already which started all the activity with caliber bio/ibio inc--investors were stupid to sell ibio back when it ran up to 3.00 or more in october of last year because caliber bio/ibio were always going to get all of the funding for zmapp productioas n in addition to kentucky bio, who has a much smaller facility. I believe gates foundation will donate additional millions to ibio inc because ibio has plant making locations of its own thru its subsidiaries in germany, brazil-this one is partnered with ge healthcare and is the largest in the world--and ibio has another plant making site in japan partnering with a japanese drug company on this one.... So ibio will be able to make zmapp for the world once caliber bio/ibio get licensing from govt and map/leaf bio.... As soon as fda approves fast track designation for zmapp which they have to with all the heat on the us govt for just that...

    Sentiment: Strong Buy

  • Reply to

    You all Missed the Point in the 6o min -

    by kipk20122 Feb 16, 2015 2:23 PM
    mephistocrat mephistocrat Feb 17, 2015 12:58 AM Flag

    May wait for fda to fast track zmapp as map/leaf pharma has submitted it already which started all the activity with caliber bio/ibio inc--investors were stupid to sell ibio back when it ran up to 3.00 or more in october of last year because caliber bio/ibio were always going to get all of the funding for zmapp productioas n in addition to kentucky bio, who has a much smaller facility. I believe gates foundation will donate additional millions to ibio inc because ibio has plant making locations of its own thru its subsidiaries in germany, brazil-this one is partnered with ge healthcare and is the largest in the world--and ibio has another plant making site in japan partnering with a japanese drug company on this one.... So ibio will be able to make zmapp for the world once caliber bio/ibio get licensing from govt and map/leaf bio.... As soon as fda approves fast track designation for zmapp which they have to with all the heat on the us govt for just that...

    Sentiment: Strong Buy

  • mephistocrat mephistocrat Jan 26, 2015 3:30 PM Flag

    i am too lazy to rattle or lie candy thief... ) you will find out the hard way, like I did... Abbot never did #$%$ and wont this time either... which leaves BGMD in the same boat as last year: sell the patents and license outright to Abbot or never make a dime from it....

    Sentiment: Sell

  • mephistocrat mephistocrat Jan 26, 2015 3:25 PM Flag

    You must have just read the article on the billions to be made on Pulmonary Fibrosis billion dollar market which IBIO will be the only company funded by the Gates Foundation by using their IBioLaunch Platform to produce the only known vaccine and treatment for Our technology has been validated in multiple vaccine and therapeutic product categories, and iBio is developing a proprietary therapeutic product, IBIO-CFB03, for the treatment of idiopathic pulmonary fibrosis (IPF), systemic sclerosis, with over 10 billion dollars in annual health costs--can you say 10 billion dollars a year exclusively to Ibio.... yeah.. Organ fibrosis is responsible for health care costs exceeding $10 billion per year, and the number of deaths due to fibrosis is estimated to be double those due to cancer. Organ fibrosis is responsible for nearly half of deaths in developed countries and results in significant physical, emotional, and financial burdens as well.

    Sentiment: Strong Buy

  • Novici biotech is a private bio/pharmaceutical organization that was formed to partner with usamriid (us army medical research institute of infectious diseases) barda, fda, darpa, and any other bioshield member agency and oboma and capital hill have misdirected ebola funding to every damn thing but filovirus research into vaccination, treatments, and testing with no false positives.... It is a joke--usamriid even states in their reason for being that ebola virus cases could be man-made or natural but our government is wrong about how a person is infected, most infectious viruses usually get from animal to man by ticks or mosquitos of any ebola variant virus. Over 29 cases of ebola variant in congo last year came from one doctor and a nurse who performed an autopsy on a woman who died with child--it only takes one #$%$ doctor or nurse to start the ball rolling downhill.... Ibio has exclusive partnering deals with all players or bio researchers started by project bioshield to react to any and all biological threats to the usa: caliber biopharmaceutical is privately held and run by bioshield or barda, same deal with map pharma with zmapp, and ibio also inked collaboration 50-50 deal with novici biotech, another private bio/plant made creator and designer of monoclonal antibody cocktails like zmapp---monoclonal antibodies is a recurring theme with all companies heavily funded by the us govt bioshield agencies and in the case of ibio: gates foundation provided most of the funds to make ibio possible--ibio is a player and ebola is going to appear every year in different areas probably, but all experts agree ebola is forever endemic to all of africa and who knows....

    Sentiment: Strong Buy

OCLR
1.95+0.080(+4.28%)Mar 27 4:00 PMEDT